Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtech in May: market surveillance movements, reimbursement and fees reimbursement make Clinica’s top 10

This article was originally published in Clinica

Executive Summary

During the month of May, trends in reporting activities by competent authorities captured the most attention from Clinica’s readers. The month’s most-read article reported the surprise downturn in the number of reports exchanged between these EU bodies; given the effort at tighter enforcement and better communication between competent authorities, this was unexpected. But does it suggest that the tougher environment now emerging as a result of the commission medtech immediate joint action plan - launched in 2012 - is actually working and fewer events are occurring?

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT102637

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel